Literature DB >> 19569971

Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes.

Frederick K Sawe, James A McIntyre.   

Abstract

Mesh：

Year:  2009        PMID： 19569971     DOI： 10.1086/600397

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.

Authors:  G U van Zyl; W Preiser; S Potschka; A T Lundershausen; R Haubrich; D Smith
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

2.  Short communication: prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients.

Authors:  Su Jin Jeong; Min Hyung Kim; Je Eun Song; Jin Young Ahn; Sun Bean Kim; Hea Won Ann; Jae Kyung Kim; Heun Choi; Nam Su Ku; Sang Hoon Han; June Myung Kim; Davey M Smith; Hyon-Suk Kim; Jun Yong Choi
Journal:  AIDS Res Hum Retroviruses       Date:  2014-05-15       Impact factor: 2.205

3.  Treatment switching in South Indian patients on HAART: what are the predictors and consequences?

Authors:  Sara Chandy; Girija Singh; Elsa Heylen; Monica Gandhi; Maria L Ekstrand
Journal:  AIDS Care       Date:  2011-05

4.  Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.

Authors:  Gert U van Zyl; Lisa M Frenkel; Michael H Chung; Wolfgang Preiser; John W Mellors; Jean B Nachega
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

5.  Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.

Authors:  Jay Gerlach; Magda Sequeira; Vivian Alvarado; Christian Cerpas; Angel Balmaseda; Alcides Gonzalez; Tala de Los Santos; Carol E Levin; Juan Jose Amador; Gonzalo J Domingo
Journal:  J Int AIDS Soc       Date:  2010-11-05       Impact factor: 5.396

Review 6.  Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?

Authors:  N Kumarasamy; Atul Patel; Sanjay Pujari
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

7.  Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.

Authors:  Oliver Barry; Jonathan Powell; Lorna Renner; Evelyn Y Bonney; Meghan Prin; William Ampofo; Jonas Kusah; Bamenla Goka; Kwamena W C Sagoe; Veronika Shabanova; Elijah Paintsil
Journal:  BMC Infect Dis       Date:  2013-10-13       Impact factor: 3.090

8.  Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.

Authors:  Palvinder Kaur; Wei Xin Khong; Sue Yuen Wee; Eng Lee Tan; Juergen Pipper; Evelyn Koay; Kah Ying Ng; Joe Kwan Yap; Kuan Kiat Chew; Mei Ting Tan; Yee Sin Leo; Masafumi Inoue; Oon Tek Ng
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

9.  Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe.

Authors:  Pascale Ondoa; Tinei Shamu; Michelle Bronze; Maureen Wellington; Tamara Sonia Boender; Corry Manting; Kim Steegen; Rudi Luethy; Tobias Rinke de Wit
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

10.  High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.

Authors:  Cissy Kityo; Diana M Gibb; Charles F Gilks; Ruth L Goodall; Ivan Mambule; Pontiano Kaleebu; Deenan Pillay; Ronnie Kasirye; Peter Mugyenyi; A Sarah Walker; David T Dunn
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.